Autophagy inhibition sensitizes cisplatin cytotoxicity in human gastric cancer cell line Sgc7901

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 8, 2013, Pages 4685-4688

  Zhang, Hui Qing ^a   He, Bo ^a   Fang, Nian ^b   Lu, Shan ^a   Liao, Yu Qian ^a   Wan, Yi Ye ^a  

^a Jiangxi Provincial Tumor Hospital   (China)

^b NANCHANG UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; Chloroquine; Cisplatin; Gastric cancer

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; CISPLATIN; MEMBRANE PROTEIN; PROTEIN BCL 2; PROTEIN P53; TP53 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL PROLIFERATION; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; METABOLISM; PATHOLOGY; STOMACH TUMOR; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BLOTTING, WESTERN; CELL PROLIFERATION; CISPLATIN; FLOW CYTOMETRY; HUMANS; MEMBRANE PROTEINS; MICROSCOPY, FLUORESCENCE; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84885726062     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.8.4685     Document Type: Article

References (17)

1. Ashford TP, Porter KR (1962). Cytoplasmic components in hepatic cell lysosomes. J Cell Biol, 12, 198-202.
2. Bang YJ, Van Cutsem E, Feyereislova A, et al (2010). Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA), a phase 3, open-label, randomised controlled trial. Lancet, 376, 687-97.
3. Chen S, Rehman SK, Zhang W, et al (2010). Autophagy is a therapeutic target in anticancer drug resistance. Biochim Biophys Acta, 1806, 220-9.
4. Cunningham D, Allum WH, Stenning SP, et al (2006). Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med, 355, 11-20.
5. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
6. Kimura T, Takabatake Y, Takahashi A, et al (2013). Chloroquine in cancer therapy, a double-edged sword of autophagy. Cancer Res, 73, 3-7.
7. Klionsky DJ (2008). Autophagy revisited, a conversation with Christian de Duve. Autophagy, 4, 740-3.
8. Levine B, Klionsky DJ (2004). Development by self-digestion, molecular mechanisms and biological functions of autophagy. Dev Cell, 6, 463-77.
9. Levine B, Kroemer G (2008). Autophagy in the pathogenesis of disease. Cell, 132, 27-42.
10. Levy JM, Thorburn A (2011). Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacol Ther, 131, 130-41.
11. Li Y, Zhang J, Ma H (2013). Protective role of autophagy in matrine induced gastric cancer cell death. Int J Oncol, 42, 1417-26.
12. Mathew R, Karantza-Wadsworth V, White E (2007). Role of autophagy in cancer. Nat Rev Cancer, 7, 961-7.
13. Pasini F, Fraccon AP, DE Manzoni G (2011). The role of chemotherapy in metastatic gastric cancer. Anticancer Res, 31, 3543-54.
14. Ren JH, He WS, Nong L, et al (2010). Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy. Cancer Biother Radiopharm, 25, 75-80.
15. Sotelo J, Briceño E, López-González MA (2006). Adding chloroquine to conventional treatment for glioblastoma multiforme, a randomized, double-blind, placebo-controlled trial. Ann Intern Med, 144, 337-43.
16. Van Cutsem E, Moiseyenko VM, Tjulandin S, et al (2006). Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer, a report of the V325 Study Group. J Clin Oncol, 24, 4991-7.
17. White E (2012). Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer, 12, 401-10.